Table 3 Baseline and follow-up clinical characteristics in the remission group and non-remission group
Characteristic | Remission (n = 104) | Non-Remission (n = 82) | P |
|---|---|---|---|
Baseline | |||
Age at biopsy (years) | 47.7 ± 13.0 | 50.8 ± 13.8 | 0.120 |
Male (n, %) | 44 (42.3) | 60 (73.1) | < 0.001 |
SCr (μmol/L) | 64.8 ± 22.1 | 74.0 ± 22.1 | 0.006 |
eGFR (ml/min/1.73m2) | 103.8 ± 20.5 | 97.0 ± 20.5 | 0.025 |
Urea (mmol/L) | 5.2 ± 2.0 | 6.0 ± 2.3 | 0.017 |
Alb (g/L) | 31.0 ± 24.7 | 25.1 ± 6.2 | 0.038 |
UA (μmol/L) | 365.1 ± 104.9 | 368.0 ± 92.7 | 0.871 |
24 h-u-pro (g/d) | 4.05 (1.97,6.31) | 4.28 (2.49,8.66) | 0.059 |
Hypertension (n, %) | 30 (28.8) | 22 (26.8) | 0.761 |
Follow-up | |||
SCr (μmol/L) | 68.4 ± 18.8 | 122.8 ± 126.6 | < 0.001 |
eGFR (ml/min/1.73 m2) | 100.0 ± 20.1 | 77.1 ± 35.3 | < 0.001 |
Urea (mmol/L) | 5.5 ± 1.9 | 8.0 ± 4.0 | < 0.001 |
Alb (g/L) | 41.1 ± 5.17 | 30.4 ± 8.24 | < 0.001 |
UA (μmol/L) | 358.5 ± 95.1 | 392.8 ± 118.1 | 0.037 |
24 h-u-pro (g/d) | 0.23 (0.76,1.05) | 3.01 (2.06,7.95) | < 0.001 |